Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Sexually Transmitted Diseases (STD) Diagnostics Market Size | 2022 - 2028 | CAGR 8.3% | To Accrue USD 256 Bn By 2028: Industry Share, Trends, Forecast Report by Zion Market Research

This image opens in the lightbox

News provided by

Zion Market Research

16 Mar, 2022, 12:30 GMT

Share this article

Share toX

Share this article

Share toX

NEW YORK, March 16, 2022 /PRNewswire/ -- As per Zion Market Research study, Sexually Transmitted Diseases (STD) Diagnostics Market is slated to cross USD 256 Billion By 2028, as per new research study by Zion Market Research Private Limited. It earned USD 151 Billion in 2021 and will register CAGR of about 8.3% in 2022-2028. Additionally, growth of sexually transmitted diseases (STD) diagnostics market over forecasting timespan is owing to rise in populace having many sex partners. In addition to this, awareness about sexual diseases among people and availability of diagnostics equipment with new features has created new growth opportunities for industry. Furthermore, growing risk of HIVs has resulted into huge demand for sexually transmitted diseases diagnostics activities in recent years. Rise in demand for advanced diagnostic devices and newly added features to this equipment will produce new growth avenues for Sexually Transmitted Diseases (STD) Diagnostics industry.

Zion Market Research published the latest report titled as "Sexually Transmitted Diseases (STD) Diagnostics Market- By Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, And Human Immunodeficiency Virus Testing), By Testing Devices (Laboratory Equipment And Point Of Care Equipment): Global Industry Perspective, Comprehensive Analysis, And Forecast, 2022–2028."  into their research database.

Sexually Transmitted Diseases (STD) Diagnostics Market: Overview

Early diagnosing of sexually transmitted diseases is predicted to minimize effect of disease on human health. Reportedly, if sexually transmitted diseases such as syphilis, gonorrhea, human papillomavirus, chlamydia, and genital herpes are not treated in time, it can result in long-term complications in affected persons. These complications encompass mental retardation, blindness, infertility, birth defects, cancer, heart disorders, and bone deformities in patients. Moreover, healthcare service providers diagnose sexually transmitted diseases through physically examination of subjects, blood tests, and through use of swabbed cultures at labs. Sexual transmitted diseases (STD) diagnosis involves lab testing and screening. Lab tests can recognize cause and identify co-infection through testing of blood, urine, and fluid samples. For the record, sexually transmitted disease patients are treated by prescribing them medications such as antiviral drugs and antibiotics.  

Furthermore, researchers at NIAID had carried out immunological studies for knowing as to why large number of sexually transmitted ailments in individuals is asymptomatic. Moreover, these studies have unleashed that how mutation in the infection accounted notably towards drug resistance in STD patients due to constant infection & co-infection. This can pose a big challenge to growth of Sexually Transmitted Diseases (STD) Diagnostics Marketdiagnostics market.

Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/std-diagnostics-market

Our Free Sample Report Includes:

  • 2022 Updated Report Introduction, Overview, and In-depth industry analysis
  • COVID-19 Pandemic Outbreak Impact Analysis Included
  • 184 + Pages Research Report (Inclusion of Updated Research)
  • Provide Chapter-wise guidance on Request
  • 2021 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
  • Includes Updated List of tables & figures
  • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
  • Zion Market Research methodology

Industry Dynamics:

  • Growth Drivers: Rise in awareness about educational campaigns and supportive government schemes will proliferate size of Sexually Transmitted Diseases (STD) Diagnostics Marketdiagnostics market over ensuing years. Furthermore, increase in persons having living relationships with many partners and people having sexual encounters with more than one partner resulting in causing of sexually transmitted diseases will boost market trends.
  • Restraints: Growing importance of sex education and reduction in taboo related to discussion over topics such as sexual activities & sexual arousal will hinder market surge. Rise in awareness about spread of sexually transmitted diseases such as HIV and need of avoiding it by taking preventive measures such as use of condoms can decrement growth of Sexually Transmitted Diseases (STD) Diagnostics Marketdiagnostics market.
  • Opportunities: Rise in point of care testing activities due to influx of new diagnostic kits, reagents, and instruments will create new growth avenues for Sexually Transmitted Diseases (STD) Diagnostics Marketdiagnostics market. Reportedly, technologically advanced equipment in diagnostics domain offers precise testing outcomes, thereby driving market size.
  • Challenges: Fluctuating costs of raw materials impacting demand and supply of diagnostics devices has severely impacted import & export of raw materials as well as production of sexually transmitted diseases devices, thereby posing a huge challenge to expansion of Sexually Transmitted Diseases (STD) Diagnostics Marketdiagnostics market.

Directly Purchase a Copy of the Report @ https://www.zionmarketresearch.com/buynow/su/std-diagnostics-market

Sexually Transmitted Diseases (STD) Diagnostics Market: Segmentation

Based on segmentation, Sexually Transmitted Diseases (STD) Diagnostics Marketdiagnostics market is segregated into type and testing devices. Based on type, the market is divided into chlamydia testing, gonorrhea testing, human papilloma virus testing, syphilis testing, herpes simplex virus testing, and human immunodeficiency virus testing. In terms of testing devices, the industry is sectored into laboratory equipment and point of care equipment.

Get More Insight before Buying @: https://www.zionmarketresearch.com/inquiry/std-diagnostics-market

Chlamydia Testing To Dominate Type Segment Over 2022-2028

Growth of chlamydia testing segment over forecasting timeframe can be attributed to low barrier protection and less awareness about chlamydia disease in under-developed and third world countries.

List of Key Players of Sexually Transmitted Diseases (STD) Diagnostics Market:

  • Cepheid Inc.
  • Roche Holdings AG
  • Affymetrix
  • Abbott Laboratories
  • Becton Dickinson and Company
  • DiaSorin
  • Hologic Inc.
  • Danaher Corporation
  • bioMerieux SA
  • Orasure Technologies.

Key Industry Insights & Finding of the Sexually Transmitted Diseases (STD) Diagnostics Market Reports:

  • As per the analysis shared by our research analyst, the Sexually Transmitted Diseases (STD) Diagnostics Market is expected to grow annually at a CAGR of around 8.3% (2022-2028).
  • Through the primary research, it was established that the Sexually Transmitted Diseases (STD) Diagnostics Market was valued approximately USD 151 billion in 2021 and is projected to reach to roughly USD 256 billion by 2028.
  • Regional government schemes for bringing improvement in sexual health of individuals will drive regional market growth.

Key questions answered in this report:

  • What are the growth rate forecast and market size for Sexually Transmitted Diseases (STD) Diagnostics Market?
  • What are the key driving factors propelling the Sexually Transmitted Diseases (STD) Diagnostics Market forward?
  • What are the most important companies in the Sexually Transmitted Diseases (STD) Diagnostics Market Industry?
  • What segments does the Sexually Transmitted Diseases (STD) Diagnostics Market cover?
  • How can I receive a free copy of the Sexually Transmitted Diseases (STD) Diagnostics Market sample report and company profiles?

Report Scope:

Report Attribute

Details

Market size value in 2021

USD 151 Billion

Revenue forecast in 2028

USD 256 Billion

Growth Rate

CAGR of almost 8.3% 2022-2028

Base Year

2020

Historic Years

2016 - 2021

Forecast Years

2022 - 2028

Segments Covered

By Product Type, By Application, and By End Use

Forecast Units

Value (USD Billion), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2022 to 2028

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others

Companies Covered

Cepheid Inc., Roche Holdings AG, Affymetrix, Abbott Laboratories, Becton Dickinson and Company, DiaSorin, Hologic Inc., Danaher Corporation, bioMerieux SA, and Orasure Technologies.

Report Coverage

Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Customization Scope

Avail customized purchase options to meet your exact research needs.  

https://www.zionmarketresearch.com/custom/558

Laboratory Equipment Segment To Contribute Humungously Towards Market Size By 2028

Massive demand for laboratory devices for testing & diagnosing sexually transmitted diseases in individuals will boost segmental growth. Furthermore, most of diagnostic testing takes place in labs, thereby generating huge need of lab equipment. 

Free Brochure: https://www.zionmarketresearch.com/requestbrochure/std-diagnostics-market

Breakthroughs in Sexually Transmitted Diseases (STD) Diagnostics Market:

  • In April 2019, Quest Diagnostics introduced three laboratory testing packages for diagnosing sexually transmitted diseases in the U.S. Reportedly, these packages can be purchased online for diagnosing frequently occurring sexually transmitted diseases across the U.S.
  • In February 2022, Lupin Limited – Mumbai-based Indian Pharmaceutical firm- received approval from U.S. FDA for use of its antibiotic Solosec for treating sexually transmitted infection referred as trichomoniasis and vaginal infection termed as bacterial vaginosis in women.
  • In February 2022, Trinity Biotech – a Medical Laboratory Company based in Ireland & specializing in production and marketing of clinically diagnostic products- has got approval of WHO for HIV screening test.

Regional Dominance:

Asia Pacific Sexually Transmitted Diseases (STD) Diagnostics Market To Witness Sizable Surge In 2022-2028

Expansion of regional market over assessment period is due to lesser use of contraceptives by both men and women in underdeveloped as well as developing economies & rural areas of sub-continent. Apart from this, favorable regional government schemes for bringing improvement in sexual health of individuals will drive regional market growth.

Global Sexually Transmitted Diseases (STD) Diagnostics Market is segmented as follows:

 Sexually Transmitted Diseases (STD) Diagnostics Market: By Type Outlook (2022-2028)

  • Chlamydia Testing
  • Syphilis Testing
  • Gonorrhea Testing
  • Herpes Simplex Virus Testing
  • Human Papilloma Virus Testing
  • Human Immunodeficiency Virus Testing

 Sexually Transmitted Diseases (STD) Diagnostics Market: By Testing Devices Outlook (2022-2028)

  • Laboratory Equipment
  • Point of Care Equipment

Sexually Transmitted Diseases (STD) Diagnostics Market: By Region Outlook (2022-2028)

North America

  • The U.S.
  • Canada

Europe

  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Press Release For Sexually Transmitted Diseases (STD) Diagnostics Market: https://www.zionmarketresearch.com/news/sexually-transmitted-diseases-std-diagnostics-market-to-hit

Browse Other Related Research Reports from Zion Market Research

  • Healthcare Contract Development and Manufacturing Organization Market: The global Healthcare Contract Development and Manufacturing Organization Market accrued earnings worth approximately 207.2 (USD Billion) in 2020 and is predicted to gain revenue of about 390.1 (USD Billion) by 2028, is set to record a CAGR of nearly 8.7% over the period from 2021 to 2028.
  • Women's Digital Health Market: The global Women's Digital Health Market accrued earnings worth approximately 1.7 (USD Billion) in 2020 and is predicted to gain revenue of about 7.2 (USD Billion) by 2028, is set to record a CAGR of nearly 20.2% over the period from 2021 to 2028.
  • Human Microbiome Market: Global human microbiome market expected to generate revenue of around USD 1,365.49 million by the end of 2024, growing at a CAGR of around 9.40% between 2018 and 2024. The human microbiome is the genetic material of microbes such as bacteria, protozoa, viruses, and fungi which are present in or on a human body.

Browse through Zion Market Research's coverage of the Global Healthcare Industry

Follow Us on LinkedIn: https://www.linkedin.com/company/zion-market-research/

Follow Us on Twitter: https://twitter.com/zion_research

Follow Us on Facebook: https://www.facebook.com/zionmarketresearch/

About Us

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research 
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@zionmarketresearch.com 
Website: https://www.zionmarketresearch.com/ 
Blog - https://zmrblog.com/ 

Logo: https://mma.prnewswire.com/media/1605489/Zion_Market_Research_Logo.jpg  

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.